Dr. Paul M. Armistead, MD, PhD

  • Chapel Hill, NC
  • Hematologist and oncologist
NPI1235221524PAC ID8921026204
Medicare services, 2024
259
Medicare patients, 2024
51
Part D claims, 2024
489
Publications
67
Clinical trials
6
Practice address
101 Manning Drive, Chapel Hill, NC 27514
Practice phone
Call (919) 966-4141
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UNC Hospitals

Hospital · Chapel Hill, North Carolina

See all 3 affiliations

Find Dr. Armistead's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Paul M. Armistead is a hematologist and oncologist in Chapel Hill, North Carolina

Dr. Armistead practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Armistead's NPI, 1235221524, was assigned on September 28, 2006. Dr. Armistead graduated from University of North Carolina School of Medicine in 2002. Dr. Armistead's North Carolina license number on file is 2008-02020.

NPI and contact details
Medicare PAC ID
8921026204
NPI enumeration date
September 28, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(919) 966-4141
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Paul M. Armistead practices at UNC Hospitals in Chapel Hill, North Carolina

Dr. Armistead's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

  • UNC Hospitals
    101 Manning Drive, Chapel Hill, NC 27514 · Orange CountyPhone(919) 966-4141

Source: Dmand AI Affiliation Data

Dr. Paul M. Armistead is affiliated with 2 sites of care and 1 medical group

Dr. Armistead's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Armistead to 1 more therapy and rehab clinic, named with a free account.

See all 3 affiliations for Dr. Armistead

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Paul M. Armistead's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Armistead practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UNC HospitalsAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Armistead practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of North Carolina Health Care System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Paul M. Armistead is one of 420 hematologists and oncologists in North Carolina

Hematology and oncology is Dr. Armistead's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Armistead is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Armistead's licenses on file in 3 states: North Carolina, Texas and Massachusetts.

Specialties and state licenses

  • Hematology and oncology, North CarolinaPrimaryLicense 2008-02020 · 2008 to 2025 · taxonomy 207RH0003X
  • Internal medicine, TexasLicense M1008 · 2005 to 2010 · taxonomy 207R00000X
  • Massachusetts license2004 to 2005

Clinical focus

Dmand AI lists lymphoma and multiple myeloma among the conditions Dr. Armistead treats.

Hematologists and oncologists near Dr. Armistead

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Paul M. Armistead billed Medicare for 259 services in 2024

CMS data shows 259 Medicare services from Dr. Armistead across 4 procedure codes in 2024, for 51 Medicare patients. Medicare paid $16,730 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024259
Medicare patients51
Paid by Medicare$16,730
Procedure codes4

Dr. Armistead's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1772024: 1704%
Other services
2023: 02024: 89

Dr. Armistead compared with the North Carolina median for hematologists and oncologists, 2024

  • Dr. Armistead
  • North Carolina median
Medicare services
259vs 45042% below
Medicare patients
51vs 18072% below
Part D claims
326vs 324Close to median

Medians across 402 hematologists and oncologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Armistead's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Armistead

Need commercial claims for Dr. Armistead?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Armistead and other hematologists and oncologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Paul M. Armistead treated 51 Medicare patients in 2024, average age 66

CMS counts 51 Medicare patients who saw Dr. Armistead in 2024. The largest group is 65 to 74, with 33 patients. 65% of them have high blood pressure, and 63% have high cholesterol. Their average risk score is 3.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Armistead's median patient age at 69, with 43% women.

Medicare patients, 202451
Average age66
Average risk score3.44

Dr. Armistead's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Armistead's Medicare patients by sex, 2024

  • Women2039%
  • Men3161%

Chronic conditions among Dr. Armistead's Medicare patients, 2024

  1. High blood pressure65%
  2. High cholesterol63%
  3. Anxiety51%
  4. Arthritis47%
  5. Mood disorders27%
  6. Depression25%
  7. Ischemic heart disease25%
  8. Atrial fibrillation24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Armistead's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women43%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Paul M. Armistead wrote 489 Medicare Part D claims in 2024

In 2024, Dr. Armistead wrote 489 Medicare Part D claims for 33 patients. 79% of them were for generic drugs. CMS names the drug for 326 of them, across 15 drugs with 11 or more claims each, at $1,312,411 in total drug cost. In 2023, CMS named 366 claims across 16 drugs.

Part D claims, 2024489
Drugs named by CMS15
Total drug cost$1.3M
Part D patients33

Dr. Armistead's Part D claims by kind of drug, 2024

  • Generic387 claims79%
  • Brand-name and other102 claims21%

Dr. Armistead's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Armistead's Part D claims, 2024

  • Antibiotics8%40 of 489 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3662024: 32611%

Drugs named by CMS: 15 in 2024, 16 in 2023.

See all prescribing by Dr. Armistead

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Paul M. Armistead takes part in Medicare

Dr. Armistead accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Armistead by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Paul M. Armistead has 67 publications on record

Dmand AI links 67 papers to Dr. Armistead, published from 2008 to 2024. 2014 was the busiest year, with 6. The most frequent topics are Hematopoietic Stem Cell Transplantation, Transplantation, Homologous and Cell Line, Tumor. Dr. Armistead has published most often in Biol Blood Marrow Transplant. Dr. Armistead's most frequent co-authors are Jeffrey J. Molldrem, MD, Marcie L. Riches, MD and Don A. Gabriel, MD.

Papers67
Years published2008 to 2024

Dr. Armistead's papers by year, 2014 to 2024

Topics Dr. Armistead writes about most

  • Hematopoietic Stem Cell Transplantation
  • Transplantation, Homologous
  • Cell Line, Tumor
  • Graft vs Host Disease
  • Leukemia, Myeloid, Acute
  • Antigens, Neoplasm
  • Transplantation Conditioning
  • Cells, Cultured

Dr. Armistead's most frequent co-authors

Recent publications by Dr. Armistead

See all 67 publications and co-authors

See who Dr. Armistead researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Armistead works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Paul M. Armistead has worked on 6 clinical trials

Dmand AI links Dr. Armistead to 6 clinical trials. 3 are still active or recruiting. Conditions studied include Lymphoma, Non-Hodgkin, Hodgkin Disease and Leukemia, Myeloid, Acute. UNC Lineberger Comprehensive Cancer Center sponsors the most, 5.

Clinical trials with Dr. Armistead by phase

  1. 1Phase 1: 1 trial
  2. 1Phase 1/2: 1 trial
  3. 1Phase 2: 1 trial
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Armistead's trials

  • Lymphoma, Non-Hodgkin
  • Hodgkin Disease
  • Leukemia, Myeloid, Acute
  • Lymphoma, T-Cell, Peripheral
  • Neoplasm, Residual

Investigators on the most trials with Dr. Armistead

Recent clinical trials with Dr. Armistead

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Paul M. Armistead received $9,347 in industry payments from 2024 to 2025

CMS Open Payments shows 23 general payments to Dr. Armistead from 11 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 73% of the total. Kite Pharma, Inc. paid the most, $7,299.

General payments to Dr. Armistead by program year, 2024 to 2025

General payments to Dr. Armistead by kind, 2024 to 2025

$9.3Kin total
  • Consulting fees$6,81073%
  • Food and beverage$2,22024%
  • Travel and lodging$3173%

Companies that paid Dr. Armistead the most, 2024 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Armistead

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Paul M. Armistead graduated from University of North Carolina School of Medicine

Dr. Armistead graduated from University of North Carolina School of Medicine in 2002.

  1. Medical schoolUniversity of North Carolina School of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Paul M. Armistead accepts plans from 18 insurance carriers

Dr. Armistead is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Aetna
  • Elevance
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross and Blue Shield of North Carolina
  • Cigna
  • HCSC
  • Aspirus Health Plan
  • +10 more carriersWith a free account

Plan types Dr. Armistead accepts, by number of carriers

  1. PPO11
  2. Medicare10
  3. HMO9
  4. POS5
  5. EPO4
  6. Medicaid2

Source: Dmand AI Insurance Network Data

Sources for Dr. Paul M. Armistead's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Paul M. Armistead

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Paul M. Armistead's NPI number?

Dr. Paul M. Armistead's NPI number is 1235221524. It was assigned on September 28, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Paul M. Armistead?

Dr. Paul M. Armistead is a hematologist and oncologist in Chapel Hill, North Carolina. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Paul M. Armistead practice?

Dr. Armistead practices at 101 Manning Drive, Chapel Hill, NC 27514. Dr. Armistead's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. Dmand AI also links Dr. Armistead to 1 therapy and rehab clinic.

What is Dr. Paul M. Armistead's office phone number?

The practice phone on file for Dr. Armistead is (919) 966-4141.

What is Dr. Paul M. Armistead's medical license number?

Dr. Armistead's North Carolina license number on file is 2008-02020, one of the licenses on file in 3 states.

Which states has Dr. Paul M. Armistead been licensed in?

Dmand AI has state licenses on file for Dr. Armistead in North Carolina (2008 to 2025), Texas (2005 to 2010) and Massachusetts (2004 to 2005).

Which hospitals is Dr. Paul M. Armistead affiliated with?

Dr. Armistead practices at UNC Hospitals in Chapel Hill, North Carolina.

What medical group is Dr. Paul M. Armistead part of?

Dr. Armistead is linked to UNC Faculty Physicians.

Does Dr. Paul M. Armistead accept Medicare?

Yes. CMS data shows Dr. Armistead billed Medicare for 259 services in 2024, and Dr. Armistead accepts Medicare assignment.

How many Medicare patients does Dr. Paul M. Armistead see?

CMS counts 51 Medicare patients who saw Dr. Armistead in 2024, with an average age of 66.

Show 9 more questionsShow fewer questions

Is Dr. Paul M. Armistead board certified?

Yes. Dr. Armistead is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Paul M. Armistead bill to Medicare?

In 2024, Dr. Armistead's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and medicare service (G2211).

Where did Dr. Paul M. Armistead go to medical school?

Dr. Armistead graduated from University of North Carolina School of Medicine in 2002.

What drugs does Dr. Paul M. Armistead prescribe most?

In 2024 Medicare Part D data, Dr. Armistead's most prescribed drugs by claims were Valacyclovir, Jakafi and Rezurock.

Has Dr. Paul M. Armistead received payments from drug or device companies?

CMS Open Payments shows $9,347 in general payments to Dr. Armistead from 11 companies from 2024 to 2025. The largest total came from Kite Pharma, Inc.

How long has Dr. Paul M. Armistead been practicing?

Dr. Armistead graduated from medical school in 2002, 24 years ago.

Does Dr. Paul M. Armistead do research?

Dmand AI links 67 publications to Dr. Armistead, published from 2008 to 2024. Dr. Armistead has worked on 6 clinical trials.

Who does Dr. Paul M. Armistead publish with?

Dr. Armistead's most frequent co-authors are Jeffrey J. Molldrem, MD (6 shared papers), Marcie L. Riches, MD (6 shared papers) and Don A. Gabriel, MD (5 shared papers).

What insurance does Dr. Paul M. Armistead accept?

Dr. Armistead is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)